Document is current
Any future updates will be listed below
-
Authors
Chu, Huaqing
Wang, Baona
Wei, Shijing
Xu, Xiyuan
Zhao, Runzhi
Li, Shuai
Hou, Qi
Hou, Yu
Zou, Liang
Lei, Wendong
Zheng, Hui https://orcid.org/0000-0002-7995-5808
-
Funding
Funding for this research was provided by:
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2021L05)
Beijing Hope Run Special Fund of Cancer Foundation of China (LC2022A17)
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 27 July 2025
Accepted: 30 July 2025
First Online: 28 September 2025
Declarations
:
: This article does not contain any studies with animals performed by any of the authors. The trial was pre-registered at on 07 September 2021 (ChiCTR2100050902). The protocol was approved by the Ethics Committee of National Cancer Center/Chinese Academy of Medical Sciences and Peking Union Medical College Cancer Hospital (approval number: 2021071214592502). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and according to the guidelines of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants included in the study.
: All authors gave their consent for publication.
: The authors declare that they have no competing interests.
